open access

Vol 11, No 3 (2006)
Published online: 2006-01-01
Submitted: 2005-12-09
Get Citation

Marjolin's ulcer: malignant neoplasm arising in scars

Urszula Ochenduszkiewicz, Rafał Matkowski, Bartłomiej Szynglarewicz, Jan Kornafel
DOI: 10.1016/S1507-1367(06)71058-6
·
Rep Pract Oncol Radiother 2006;11(3):135-138.

open access

Vol 11, No 3 (2006)
Published online: 2006-01-01
Submitted: 2005-12-09

Abstract

Malignant neoplasm arising in chronic, non-healing wounds has been known since ages and it was named Marjolin's ulcer about one hundred years ago. This scar malignancy arises in burned, constantly injured or chronically inflamed skin. Such pathologies as osteomyelitis, decubitus ulcers, chronic fistulas, frost bite, chronic venous failure, vaccination sites, skin graft donor sites and chronically traumatized skin are numbered among the etiological factors. Despite these numerous risk factors this oncological syndrome is rarely diagnosed and commonly mistaken, thus it may often be overlooked. Marjolin's ulcer may be defined by many pathological types of neoplasms. Squamous cell carcinoma (SCC) is the most commonly identified histological type followed by basal cell carcinoma (BCC), malignant melanoma, sarcomas (fibrosarcoma, liposarcoma, dermatofi-brosarcoma protuberans, mesenchymal tumor), mixed tumors: SCC-BCC, SCC-melanoma and others. There is an agreement over the prevention methods with skin grafting of burned areas and excision with simultaneous grafting of ulcerations appearing in non-healing wounds. To date, there has not been a consensus reached over the treatment protocol. Wide surgical excision seems to be the most preferred method. Inoperable cases and recurrences may be treated with radiotherapy alone or combined with chemotherapy.

Abstract

Malignant neoplasm arising in chronic, non-healing wounds has been known since ages and it was named Marjolin's ulcer about one hundred years ago. This scar malignancy arises in burned, constantly injured or chronically inflamed skin. Such pathologies as osteomyelitis, decubitus ulcers, chronic fistulas, frost bite, chronic venous failure, vaccination sites, skin graft donor sites and chronically traumatized skin are numbered among the etiological factors. Despite these numerous risk factors this oncological syndrome is rarely diagnosed and commonly mistaken, thus it may often be overlooked. Marjolin's ulcer may be defined by many pathological types of neoplasms. Squamous cell carcinoma (SCC) is the most commonly identified histological type followed by basal cell carcinoma (BCC), malignant melanoma, sarcomas (fibrosarcoma, liposarcoma, dermatofi-brosarcoma protuberans, mesenchymal tumor), mixed tumors: SCC-BCC, SCC-melanoma and others. There is an agreement over the prevention methods with skin grafting of burned areas and excision with simultaneous grafting of ulcerations appearing in non-healing wounds. To date, there has not been a consensus reached over the treatment protocol. Wide surgical excision seems to be the most preferred method. Inoperable cases and recurrences may be treated with radiotherapy alone or combined with chemotherapy.

Get Citation

Keywords

skin neoplasm; burn scar; scar malignancy; Marjolin' s ulcer

About this article
Title

Marjolin's ulcer: malignant neoplasm arising in scars

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 11, No 3 (2006)

Pages

135-138

Published online

2006-01-01

DOI

10.1016/S1507-1367(06)71058-6

Bibliographic record

Rep Pract Oncol Radiother 2006;11(3):135-138.

Keywords

skin neoplasm
burn scar
scar malignancy
Marjolin's ulcer

Authors

Urszula Ochenduszkiewicz
Rafał Matkowski
Bartłomiej Szynglarewicz
Jan Kornafel

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl